semaglutide ban FDA on Compounded GLP-1 Drugs: What to Know Is Compounded Semaglutide Being Banned?

Distribution Channel 14.2.9

As a FDA registered 503b we exclusively sell to licensed doctors' offices and pharmacies, not directly to patients, guaranteeing professional handling of the product

Boehringer Ingelheim announced positive Phase III results for survodutide, a glucagon/GLP-1 dual agonist, showing weight loss and metabolic improvement in obesity and overweight populations, while also building evidence in MASLD-related metabolic disease

Given the rich lipid content of the nervous system, hemoglobin-derived iron works with lipid peroxidation to induce ferroptosis, which eventually leads to neuronal mitochondrial damage, edema, and apoptosis of neurons and astrocytes

Nucleic Acids Res 37, D933D937, doi: 10.1093/nar/gkn823 (2009)